These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10115050)

  • 1. Experimental treatment: who pays?
    Lenow JL; Quentzel S
    Bus Health; 1991 Oct; 9(11):104-5. PubMed ID: 10115050
    [No Abstract]   [Full Text] [Related]  

  • 2. When an insurer calls your treatment experimental.
    Holoweiko M
    Med Econ; 1995 Sep; 72(17):171-2, 175-6, 178-82. PubMed ID: 10151340
    [No Abstract]   [Full Text] [Related]  

  • 3. Technology development from the perspective of industry.
    Abele JE
    J Invasive Cardiol; 1993 Mar; 5(2):65-8. PubMed ID: 10171667
    [No Abstract]   [Full Text] [Related]  

  • 4. Who should be responsible?
    Brown E
    Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532
    [No Abstract]   [Full Text] [Related]  

  • 5. Resources for assessing innovations in mechanical ventilatory support: the missing link.
    East TD
    Respir Care; 1995 Sep; 40(9):987-93. PubMed ID: 10152245
    [No Abstract]   [Full Text] [Related]  

  • 6. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments?
    Fisfis BA
    Spec Law Dig Health Care Law; 1994 Mar; (181):9-32. PubMed ID: 10133063
    [No Abstract]   [Full Text] [Related]  

  • 7. Who pays for new technology?
    Kirchner M
    Bus Health; 1991 Oct; 9(11):20, 22, 24-5. PubMed ID: 10115053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental treatment: can you do the right thing without going broke?
    Holoweiko M
    Bus Health; 1995 May; 13(5):38-40, 45-6, 48. PubMed ID: 10164496
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of medical-technology strategies: proposal for an institute for health-care evaluation (second of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(11):687-92. PubMed ID: 7035949
    [No Abstract]   [Full Text] [Related]  

  • 11. Hammering back at the insurance industry.
    Tabas AM; Tolin SA
    J Patient Acc Manage; 1980 Jan; ():10-3. PubMed ID: 10245929
    [No Abstract]   [Full Text] [Related]  

  • 12. Can surgical innovation survive? Panel presentations.
    McKneally MF; Gleeson S; Balch CM; Mussallem MA; Abel DB; Bernhard VM
    Bull Am Coll Surg; 1996 Apr; 81(4):8-21, 43. PubMed ID: 10156765
    [No Abstract]   [Full Text] [Related]  

  • 13. Questioning technology. Calif. Blues' foundation grant spearheads research.
    Benko LB
    Mod Healthc; 2006 Sep; 36(37):10, 12. PubMed ID: 17037828
    [No Abstract]   [Full Text] [Related]  

  • 14. The McCarran-Ferguson Act's antitrust exemption for insurance: language, history and policy.
    Weller CD
    Duke Law J; 1978 May; (2):587-643. PubMed ID: 10239067
    [No Abstract]   [Full Text] [Related]  

  • 15. Anxious for reform, Congress targets health insurance industry.
    Burke M
    Hospitals; 1991 Jun; 65(12):38, 40. PubMed ID: 2040494
    [No Abstract]   [Full Text] [Related]  

  • 16. Will insurers pay for high-tech care?
    Crane M
    Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091
    [No Abstract]   [Full Text] [Related]  

  • 17. No future guarantees for self-insured plans.
    Feezor A
    Bus Health; 1987 Apr; 4(6):16-9. PubMed ID: 10281226
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining experimental therapy--a third-party payer's dilemma.
    Newcomer LN
    N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
    [No Abstract]   [Full Text] [Related]  

  • 19. ERISA preemption of state mandated-provider laws.
    McDonough RS
    Duke Law J; 1985 Dec; (6):1194-216. PubMed ID: 10276650
    [No Abstract]   [Full Text] [Related]  

  • 20. A proposed new role for the insurance industry in biomedical research funding.
    Kahn CR
    N Engl J Med; 1984 Jan; 310(4):257-8. PubMed ID: 6690943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.